Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.
about
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesBiomarkers for CNS involvement in pediatric lupusPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusAnti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue diseaseNeuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE.C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.Association of IRF5 polymorphisms with activation of the interferon alpha pathwayNeuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.The type I interferon system in the etiopathogenesis of autoimmune diseases.Type I interferon and systemic lupus erythematosus.Cutting edge: Antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction.Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes.Sensors of the innate immune system: their link to rheumatic diseases.TNF-α and TGF-β counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus.Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLEBehavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.Developments in the clinical understanding of lupusThe impact and implications of neuropsychiatric systemic lupus erythematosus in adolescents.Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients?Potential role of IFNα in adult lupus.Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application.Diagnosis and management of neuropsychiatric SLE.Interferons in the central nervous system: a few instruments play many tunes.Complement, c1q, and c1q-related molecules regulate macrophage polarization.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.Microglia-dependent synapse loss in type I interferon-mediated lupus.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.
P2860
Q26774815-8DAF4CA0-1BD5-4DE4-8FA8-CF2D60989C75Q28082493-88FDEE9D-40AB-436D-ABCE-5DB3C6A3D013Q28088753-EA522B64-15D6-497D-9693-F834B9DD2976Q28268802-59AE7539-5B6D-4A20-9075-3D01509AEA02Q28290942-39D9988D-6694-4803-AE42-BA064BA58A3AQ30727936-1AD46C30-0947-4D70-8DAB-E5DA08DC7450Q33628713-E5524DBA-1D27-4861-ADDF-D162CD8BEC8EQ33723529-A25A4653-DE12-44F8-BF3C-E7898FB23ECDQ34230589-69770E76-13A5-4534-8448-09065144F815Q34240254-FA62D9E1-CA52-45EF-A489-38FFE554384AQ34694711-860894FF-6178-43EF-9F49-01AD63EEDEE2Q34729450-315C5356-A4CC-437E-AC32-8F6313E8216FQ35102479-250E9B56-F0AD-43C0-BC9E-06C32AD62B78Q35199278-1B194D88-BC26-4175-A818-8FA53908CBA4Q35514368-76F0E365-51A0-4ED0-98D3-3B8224B169FDQ35549980-5E6AB1AF-1733-4534-8CF7-CBAE034A6087Q35589645-3E1E1E55-1E30-4FA2-94CE-FA8A66628FB2Q35616122-AE2A77A3-7307-44FD-BFEE-EC201C0D1653Q35623130-A6314B90-E181-4B3A-BC79-E65008DA4EC5Q35795451-0DB40AFD-C4A7-4BD2-9FF4-D257114D2328Q35829864-15F28161-B4A9-45EB-B53F-F3E7D291F2B0Q35902490-311657D0-57A4-42B4-9604-91D63AD63C69Q36902003-FC669964-06AB-4095-88DF-F701D4AEBDACQ37058781-AD58EE89-A154-4D05-9BFB-D045B848E126Q37453947-F7726512-A097-4249-80AA-5C0C756E9228Q37552138-586490A4-970C-4D7C-9F81-53A90BEAA428Q37606651-3ED982CA-4FC8-4A73-9960-AA7BC0677DAEQ37632131-0CB2E409-53A8-4A9A-BA33-F22DE1D1B867Q37730992-9720BD72-3853-4660-9877-3B3BA7879176Q37751877-DD912016-45C0-4680-9448-8D1374283603Q38085723-0EDF1E70-7312-410E-95C5-FC75F4F23E18Q38125979-06354963-3619-49C5-9B3F-258A84DC85F9Q38186995-8A6480F7-1B95-47FB-91B3-DBF51C67BCD4Q38192651-BE8D6878-DCCA-4B65-AC2F-34B31A7E14A3Q38246272-59399B3A-0CF9-45F5-9BEA-629A697E3860Q38247180-C5D54BD6-5A0E-48F0-965B-621FDA3642C5Q38537618-E43547CC-D7D6-4D6C-939E-BC27B04FD603Q38725841-9008095C-FA86-4ED1-A686-BFAE7900BBDBQ38774697-94029AF8-5537-4485-A561-3515B27BE9A2Q40886149-DF4637AE-7A5A-4F3F-B9F5-74DE1B52E552
P2860
Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potent induction of IFN-alpha ...... s with neuropsychiatric lupus.
@en
Potent induction of IFN-alpha ...... s with neuropsychiatric lupus.
@nl
type
label
Potent induction of IFN-alpha ...... s with neuropsychiatric lupus.
@en
Potent induction of IFN-alpha ...... s with neuropsychiatric lupus.
@nl
prefLabel
Potent induction of IFN-alpha ...... s with neuropsychiatric lupus.
@en
Potent induction of IFN-alpha ...... s with neuropsychiatric lupus.
@nl
P2093
P2860
P921
P1476
Potent induction of IFN-alpha ...... s with neuropsychiatric lupus.
@en
P2093
Deanna M Santer
Keith B Elkon
Seiji Minota
Taku Yoshio
Thomas Möller
P2860
P304
P356
10.4049/JIMMUNOL.182.2.1192
P407
P577
2009-01-01T00:00:00Z